Farzin Hadizadeh

Dr. Farzin Hadizadeh

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Life Sciences
Verified
Journal Article
Closed access
SMShirin Mollazadeh
Shirin Mollazadeh
ASAmirhossein Sahebkar
Amirhossein Sahebkar
FHFarzin Hadizadeh
Farzin Hadizadeh
JBJavad Behravan
Javad Behravan
SASepideh Arabzadeh
Sepideh Arabzadeh

1 September 2020 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MMMahdi Mirahmadi
Mahdi Mirahmadi
SAShayan Azimi-Hashemi
Shayan Azimi-Hashemi
ESEhsan Saburi
Ehsan Saburi
HKHossein Kamali
Hossein Kamali
MPMandana Pishbin
Mandana Pishbin
FHFarzin Hadizadeh
Farzin Hadizadeh
Studying prostate cancer is important due to its high annual incidences and mortality rates in the world. Although prostate cancer mortality rates are reduced using new therapy, complicated routes and side effects of these current drugs require a daily available treatment for prevention. Lycopene is a natural, prominent, and effective product which has a high value in diet. The anti-cancer effect, non-toxicity, safety and preventive or therapeutic roles of lycopene have been investigated in several studies. In the current review, we have collected information about the anti-cancer, anti-progressive and apoptotic effects of lycopene on prostate cancer. This article is a summary of the most important original and review articles on lycopene and its anticancer effects that are systematically categorized and presents information about the molecular structure, different sources, biological functions, and its in-vivo and in-vitro effects of lycopene on variety of cancerous and normal cells. The clinical studies provide a clear image for continuous use of this adjunctive dietary for different type of cancers, especially prostate cancer in men. In addition, this article discusses the various molecular pathways activated by lycopene that eventually prevent or suppress cancer. Lycopene has been found to effectively suppress the progression and proliferation, arrest in-cell cycle, and induce apoptosis of prostate cancer cells in both in-vivo and in-vitro conditions. Additionally, lycopene showed that it could modulate the signaling pathways and their protein for the treatment or prevention of prostate cancer.

1 March 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MAMona Alibolandi
Mona Alibolandi
KAKhalil Abnous
Khalil Abnous
FSFatemeh Sadeghi
Fatemeh Sadeghi
HHHossein Hosseinkhani
Hossein Hosseinkhani
MRMohammad Ramezani
Mohammad Ramezani
FHFarzin Hadizadeh
Farzin Hadizadeh

1 July 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
MAMona Alibolandi
Mona Alibolandi
MRMohammad Ramezani
Mohammad Ramezani
KAKhalil Abnous
Khalil Abnous
FSFatemeh Sadeghi
Fatemeh Sadeghi
FAFatemeh Atyabi
Fatemeh Atyabi
FHFarzin Hadizadeh
Farzin Hadizadeh

1 October 2017 in Food Research International
Verified
Journal Article
Closed access
FNFarzaneh Nasrollahzadeh
Farzaneh Nasrollahzadeh
MVMehdi Varidi
Mehdi Varidi
AKArash Koocheki
Arash Koocheki
FHFarzin Hadizadeh
Farzin Hadizadeh